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S_m.ary Photodynamic therapy of cancer exposes adjacent arteries to the nsk of injury and the possibility
of haemorrhage and thrombosis. The nature of photodynamic injury to normal arteries has not been
satisfactorily defined, and the ability of arteries to recover with time is unclear. To clarify these issues, we have
investigated the effects of PDT on rat femoral arteries, using a second-generation photosensitiser, disul-
phonated aluminium phthalocyanine, and a new method of photosensitisation, using endogenous synthesis of
protoporphyrin IX following systemic administration of 5-aminolaevulinic acid (ALA). Pharmacokinetic
studies of sensitiser fluorescence were carried out to determine peak levels of sensitiser. Subsequently
photodynamic therapy at times corresponding to maximal fluorescence was performed using two light doses,
100 and 250 J cm-2. The nature of injury sustained and recovery over a 6 month period was investigated.
Three days following PDT, all vessels treated showed complete loss of endothelium, with death of all medial
smooth muscle cells, leaving an acellular flaccid artery wall. No vascular occlusion, haemorrhage or throm-
bosis was found. A striking feature was the lack of inflammatory response in the vessel wall at any time
studied. Re-endothelialisation occurred in all vessels by 2 weeks. The phthalocyanine group showed repopula-
tion of the media with smooth muscle cells to be almost complete by 3 months. However, the ALA group
failed to redevelop a muscular wall and remained dilated at 6 months. Luminal cross-sectional area of the
ALA-treated group was significantly greater than both control and phthalocyanine groups at 6 months. All
vessels remained patent. This study indicates that arteries exposed to PDT are not at risk of catastrophic
haemorrhage or occlusion, a finding that is of significance for both the local treatment of tumours and the use
of PDT as an intraoperative adjunct to surgery for the ablation of microscopic residual malignant
disease.
Photodynamic therapy (PDT) involves the activation of
previously administered photosensitising drugs by non-
thermal laser light. This photoactivation results in the forma-
tion of short-lived toxic oxygen species which mediate
localised tissue destruction. Many studies have demonstrated
the efficiency of PDT at treating early tumours in a variety of
organs and tissues (Pass, 1993). Using current photosen-
sitisers, in order to bring about effective tumour necrosis,
adjacent normal tissues must also be subject to injury, as the
hoped-for selectivity of photosensitiser distribution to tumour
with respect to normal tissue has not been achieved. It is
therefore essential to determine the precise effect that PDT
injury will have on such normal tissues, and to establish their
ability to recover with time (Bown, 1990). In many sites in
which tumours may be treated with PDT, major blood
vessels run in close proximity to tumour being treated, and
may therefore sustain PDT injury. This consideration is
particularly pertinent to the treatment of head and neck
cancers, and two cases of fatal haemorrhage 24 and 72 h after
PDT of carcinomas which involved the carotid artery have
been reported (Schuller et al., 1985; Gluckman, 1991). How-
ever, direct tumour invasion of the artery may have taken
place in these advanced cases and the haemorrhage may not
represent the true response of the vessel itself to PDT.
Should arterial occlusion occur as a result of PDT injury,
this would also have major significance for many treatment
sites. PDT has recently been proposed as an intraoperative
adjunct to marginal surgical procedures. Ablation of micro-
scopic residual disease, for example in the peritoneal cavity
following resection of colorectal carcinomas (Abulafi et al.,
1991), or in the neck following radical neck dissection, may
decrease the incidence of locoregional recurrence. Such
'sterilisation' of the operative field would be hazardous in the
extreme if it were to place major vessels at risk of haemorr-
hage or occlusion. Microvascular occlusion is considered to
be at least in part responsible for the mechanism of PDT
necrosis (Henderson et al., 1985; Star et al., 1986; Fingar &
Henderson, 1987; Reed et al., 1988), but the vessels studied
have been artenroles, venules and capillaries. Small vessels
with relatively little mural supporting connective tissue may
be more likely to undergo occlusion or haemorrhage than
larger arteries which have more smooth muscle, collagen and
elastin components, and this study focuses on the response of
such larger vessels.
Current photosensitisers in clinical use such as Photofrin
are less than ideal (MacRobert et al., 1989). In particular, the
problem of cutaneous retention of photosensitisers results in
prolonged skin sensitivity lasting many weeks (Dougherty et
al., 1990). Limited light penetration of tissues and inadequate
selective tumour distribution are further drawbacks. New
photosensitising agents may solve some of these problems.
The use of sulphonated aluminium phthalocyanine offers the
advantage that skin photosensitivity is lower and light pene-
tration is deeper owing to its greater light absorption at
longer wavelengths. Disulphonated phthalocyanine (AlISPc)
has been shown to be a highly potent sensitiser in vivo in a
variety of animal tissues (Chatlani et al., 1991; Nuutinen et
al., 1991; Loh et al., 1992).
5-Aminolaevulinic acid (ALA) is a promising new photo-
sensitising agent that relies on the ability of tissues to syn-
thesise endogenous porphyrins following its administration
(Divaris et al., 1990; Kennedy et al., 1990; Bedwell et al.,
1992; Kennedy & Pottier, 1992; Loh et al., 1992). ALA is a
haem precursor, and its administration in excess results in the
accumulation of the photoactive intermediate protoporphyrin
IX; this temporary accumulation may be effectively exploited
for photodynamic therapy. The advantage of this method is
that ALA and its metabolites are cleared within about 24 h
of administration, thereby virtually elimninating the problem
of skin photosensitivity. Studies in animals also demonstrate
improved tumour to normal tissue ratios (Bedwell et al.,
1992), and early clinical studies have demonstrated necrosis
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in oral cavitV squamous cell carcinomas following ALA
photodynamic therapy (Grant et al.. 1993).
The purpose of this study was to evaluate the effect of
PDT using ALA and AlS2Pc on the normal femoral artery in
the rat. This is a small muscular arterv of about 0.2-0.4 mm
in diameter. consisting of an intima with endothelial cells
lying on a basement membrane and bounded by an inner
elastic lamina. a media predominantly composed of smooth
muscle cells. and an outer adventitial connective tissue layer.
Preliminary pharmacokinetic studies were undertaken to
characterise temporal sensitiser distribution patterns in indi-
vidual arterial layers and adjacent structures. This allowed
appropriate timing of PDT treatment. The nature of the
injunr was then determined at histological examination. and
the subsequent ability of vessels to recover over a prolonged
period of time was studied.
Materials and methods
Fluorescence photometry
Young adult female Wistar rats, sedated with Hypnorm (fen-
tayl and fluanisone). received either 5 mg kg-' disulphonated
aluminium phthalocyanine (as prepared by the Department
of Chemistry. Imperial College) or 200 mg kg-' 5-amino-
laevulinic acid (Sigma Chemicals) by tail vein injection in
phosphate-buffered saline. Animals were sacrificed by cervical
dislocation at serial times up to 24 h after drug administra-
tion. with at least two rats per time point being studied for
each drug group. A 2 cm length of the femoral neurovascular
bundle lying on its muscular bed was removed. Control
samples were also taken from non-sensitised rats. Specimens
were snap frozen in precooled isopentane and stored in liquid
nitrogen. Frozen sections of 10 im were cut for fluorescence
microscopy. using an inverted microscope with phase con-
trast and epifluorescence attachments using a technique
previously described (Bedwell et al.. 1992: Loh et al.. 1992).
Fluorescence was excited using an 8 mW helium neon laser
emitting at 633 nm. and detected at between 665 and 700 nm
using a combination of band-pass (Omega Optical Inc.) and
long-pass filters (Schott RG655). A highly sensitive cooled
slow-scan charged-coupled device camera (Wright Instru-
ments) coupled to a personal computer was used to detect
and digitally process the fluorescence image. Superimposition
of a computer-generated sampling area within the image was
used to obtain mean values for fluorescence. in arbitrary
units of counts per pixel. in regions of interest. Good correla-
tion has previously been shown in normal rat colon between
chemical extraction techniques and microscopic fluorescence
measurements from frozen sections. for both AlS.Pc and for
ALA-induced PPIX (Chatlani et al., 1991: Loh et al.. 1993).
Values were obtained for separate layers of the artery wall as
well as for vein and underlying skeletal muscle. Frozen sec-
tions were then stained with haematoxylin and eosin to
ensure accurate correlation and identification of relevant
structures. Three or four animals per time point were studied
with at least two readings per tissue structure being taken.
and mean values calculated allowing a plot of fluorescence
intensity versus time to be constructed.
Photodvnamic therapi
A further senres of rats were similarly sensitised with ALA
(200mg kg-1) or AlS2Pc (5 mg kg-') and then treated at
times corresponding to peak fluorescence. The rats were
anaesthetised with Hypnorm (fentanyl and fluanisone) and
diazepam. and a groin incision made on one side to expose
the femoral neurovascular bundle. care being taken to avoid
any surgical manipulation of the vessels which might result in
damage to the delicate endothelium. One centimetre segments
of the femoral artery were exposed to laser light delivered by
a copper vapour pumped tunable dye laser. Irradiation at
630 nm was used for the ALA group as in previous studies
from this unit (Bedwell et al.. 1992). although the in vi'io
excitation efficiency is slightly' higher at 635 nm (A.J. Mac-
Robert & J. Bedwell. unpublished data): 675 nm was used for
the phthalocyanine group. which is in accora with the in OVjo
action spectrum (Cubeddu et al.. 1992). For each drug eight
rats were treated per time point, four at 100 J cm-' and four
at 250 J cm-2 delivered using a surface illumination technique
over a 1 cm- area using a 400 lim fused-silica optical fibre
with a microlens attachment to ensure even light distribution.
Power density was kept below 150 mW cm to avoid ther-
mal injury. This was confirmed in selected experiments using
a copper-constantan thermocouple (Jenway. model 7905)
placed immediately below the irradiated muscle surface to
monitor temperature changes during the treatment: no rise in
temperature was detected over the treatment times for both
wavelengths and light exposures. Following PDT the mid-
point of the 1 cm treated segment was marked by a 5:0 silk
suture placed in the muscle at a distance from the treated
zone and the incisions closed. In the early phase of the
investigation some rats removed their own sutures with
wound dehiscence and sepsis: these animals were excluded
from the study and the procedure repeated in other animals
using a transverse groin incision and closure, which did not
suffer the same fate. Animals were sacrificed at 3. 7. 14. 28.
84 and 168 days (6 months), the legs severed and skin
removed, and fixed in 10% buffered formalin for 3 days. The
legs were then decalcified and two or more sections were
taken transversely through the mid-point of the treated seg-
ment. Sections were stained with haematoxyhn and eosin.
and the treated vessels identified and photographed at x 40
using a Zeiss photomicroscope. Selected specimens were
stained with elastin van Gieson for collagen and elastin. and
Martius red scarlet blue for fibrin. Three groups of control
animals were studied at 3 days and 1 week: light only at
250 J cm-' at 630 nm (two animals) and 675 nm (two
animals). and surgical exposure only (two animals). The con-
tralatera' non-treated leg was sampled in two animals from
each treatment group at each time point up to 6 months and
acted as drug-only controls.
The luminal cross-sectional areas of the arteries were then
measured on the standard photomicrographs using a
computer-aided image analysis system (Quaitimet. Q520.
Cambridge Instruments UK). Mean values were determined
for each treatment group and compared with the contra-
lateral non-treated legs. This enabled a plot of cross-sectional
area versus time to be constructed. Results were subjected to
statistical analysis using Student's t-test.
Results
Fluorescence detection
The fluorescence distribution pattern of phthalocyanine- and
ALA-induced protoporphyrin IX was similar for both drugs:
maximal arterial fluorescence was detected in the intimal
layer of each artery. Similar fluorescence was seen in the
adjacent thin-walled vein. This fluorescence may be attri-
buted to retention of circulating sensitiser by the endothelial
cells in the case of the phthalocyanine (Figure 1), and, in the
case of ALA-sensitised animals, to uptake and metabolism of
ALA to protoporphyrin IX. Less fluorescence was detected
in the arterial media. as can be seen from the derived tem-
poral fluorescence kinetic curves (Figure 2a and b) and
images (Figure 1). Medial smooth muscle fluorescence was
similar to that detected in adjacent skeletal muscle.
Peak fluorescence was detected at 1 h following sensitisa-
tion with AIS2Pc and at 3 h with ALA sensitisation. These
times were thus selected for PDT treatment in order to take
advantage of maximal presence of photosensitiser. Levels had
returned to or around background by 24 h for both ALA
and AlS,Pc. The fluorescence ratio between arterial intima
and media reached a maximum of 5: 1 for AlS.Pc and 3:1 for
ALA at the same time as peak fluorescence was detected (1
and 3 h respectively).74 W.E. GRANT et al.
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Fgwe I Fluorescence micrograph and corresponding haematox-
ylin and eosin stain of normal rat femoral artery I h following
intravenous sensitisation with 5 mg kg-' AIS2Pc. A similar dis-
tribution with maximal fluorescence of the intima and relatively
less fluorescence of the medial smooth muscle was observed
following administration of 200 mg kg-' ALA. (x 40).
Photodynamic therapy
Nature ofinjury The arteries in control animals sacrificed at
3 and 7 days were patent and showed normal endothelium
and normal media, indicating that light alone, surgical
exposure alone and drug administration alone did not cause
thermal or other significant injury. Subsequently contralateral
non-treated arteries were used as controls for morphological
comparison as these were matched for growth in the animals.
No macroscopic change in the arterial configuration was
observed at any time. No arteries underwent occlusion.
thrombosis, haemorrhage or rupture, or aneurysmal dilation,
and all remained patent.
PDT-treated arteries in each drug group and at both light
doses demonstrated a similar early response to PDT injury.
Loss of endothelium and preservation of an intact inner
elastic lamina (IEL) was characteristic. In spite of the loss of
endothelium, no thrombus formation could be detected. A
striking feature was replacement of the entire smooth muscle
cell population of the media by a homogeneous eosinophilic
layer. No smooth muscle nuclei could be detected on light
microscopy (see Figure 3a and d). There was complete loss of
muscle tone with wide dilation of the artery and smooth
configuration of the inner elastic lamina, a structure which
was observed in all controls to be corrugated owing to the
smooth muscle tone of the vessel. PDT thus appeared to
render the vessel an aceHular conduit. In spite of obvious
extensive cell death there was no evidence of an inflammatory
response at any time following treatment. The findings were
similar for both the low and high drug doses and for both
photosensitisers.
Healing recovery The lost endothelium was the first struc-
ture seen to regenerate, presumably from the adjacent normal
untreated ends of the artery, and appeared to be complete by
2 weeks in both groups (see Figure 3b and e). In the Al%SPc
group repopulation of the media with smooth muscle cells
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took between 3 and 6 months to be complete (see Figure 3c).
Only the occasional vessel showed evidence of slight neo-
intimal hyperplasia of a few cells' thickness. Normal contrac-
tility and vascular tone was seen with the return of the
corrugated appearance of the IEL. In contrast, the
ALA-PDT-treated vessels failed to repopulate the media
with smooth muscle cells. After 6 months the vessels
remained thin walled and dilated with no medial repopula-
tion (Figure 3f). The IEL remained smooth and straight,
reflecting this finding. All vessels remained patent with no
evidence of thrombosis at any stage.
The cross-sectional area of the treated vessels was
significantly greater in all treatment groups when compared
with controls up to 4 weeks. This corresponded to the
observed loss of medial muscle tone of the vessels. By 6
months the vessels had recovered in the AlS2Pc group but
remained significantly dilated in the ALA-treated group (see
Figure 4 and Table 1). However, no macroscopic aneurysmal
dilation was observed.
Dcuso
The preliminary pharmacokinetic studies based on sensitiser
fluorescence are necessary because of the relatively short
duration of peak fluorescence. The later fluorescence maxi-
mum in the ALA group reflects the time necessary for syn-
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Figwe 3 Haematoxylin and eosin light micrographs of arteries treated with PDT at times up to 6 months. Photomicrographs on
the left show arteries sensitised with 5 mg kg-' AIS2Pc and treated with 100J cm-2 laser light at 675 nm, and sacrificed at (a) 3
days, (b) 14 days and (c) 168 days. On the right are shown arteries sensitised with 200mg kg-' ALA and treated with 100 J cm-2
laser light at 630 nm, d, e and f again showing appearance at 3, 14 and 168 days respectively. At 3 days in both groups there is
complete cellular depletion throughout the vessel wall, and the intact inner elastic lamina is clearly seen. The endothelium has
regenerated by 14 days in both drug groups. At 168 days only the AIS2Pc group showed complete repopulation of the media with
functional smooth muscle cells, the ALA-treated artery remaining persistently dilated, with no medial smooth muscle cells. Scale
bar in bottom-right corner represents SOpnm for a, b, d and e ( x 100); for c, and f bar represents l00 im ( x 40).
Table I Mean (± standard error of mean) of arterial luminal cross-sectional areas
Time (daYs) Controls AlS,PcJOOJcm-2 AJS,Pc 250Jcm- ALA lOOXJcm-' ALA 250Jcm-2
3 0.011 ± 0.003 0.062 ± 0.001 0.056 ± 0.004 0.071 ± 0.007 0.065 ± 0.010
7 0.008 ± 0.002 0.056 0.002 0.050 ± 0.001 0.064 ± 0.008 0.074 ± 0.005
14 0.012 ± 0.003 0.047 ± 0.003 0.054 ± 0.003 0.043 ± 0.005 0.064 ± 0.020
28 0.009 ± 0.003 0.058 ± 0.016* 0.028 ± 0.008 NS 0.060 ± 0.005 0.066 ± 0.005*
84 0.011 ± 0.003 0.042 ± 0.011* 0.027 ± 0.009 NS 0.085 ± 0.005 0.087 ± 0.003
168 0.011 0.003 0.009 0.001 NS 0.016 ± 0.003 NS 0.096 ± 0.002 0.091 ± 0.004
Values are in nmu2 for cross-sectional areas at each time point. Figures are means, with standard error of the mean given in brackets.
Control values showed no significant difference between drug groups and therefore mean and standard error of mean values are
presented for all controls at each time point. NS, not statistically different from control values. *Significant at the P <0.05 level;
remainder significant at P <0.001Ilevel.
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Figwe 4 Mean luminal cross-sectional areas of controls (-) and
treated arties at serial times up to 6 months following PDT
ug either 5mg kg-' AIS2Pc (0, A) or 200mg kg-' ALA (A,
U) at light doses of I00Jcm2 and 250Jcm-2.
thesis and accumulation of protoporphyrin IX. Maximum
fluorescence ratios of arterial intima and vein to skeletal and
medial smooth muscle also occurred at the time of peak
fluorescence.
The observation that there was no difference in histological
response between the lOOJcM-2 and the 250Jcm-2 light
doses in either of the drug groups indicates that both light
doses are above a threshold for injury, and that above this
threshold damage does not appear to increase with light
dose. The similarity of response in the early phase following
PDT in both the ALA and AlS2Pc groups indicates that a
similar photodynamic mechanism is responsible for the injury
in each group. The patency of all treated vessels, and the lack
of evidence of thrombosis in spite of elimination of the
endothelium, is encouraging and suggests that occlusion of
major blood vessels due to PDT is unlikely to be a problem.
Furthermore, the vessel walls all rained intact, suggesting
a resistance of the injured walls to haemorrhage or disinte-
gration under physiological stresses in spite of full-thickness
cell death. Further studies (W.E. Grant, unpublished data)
confirm this preservation of the functional integrity of the
vessel wall, which appears to have been maintaind by the
preservation of an intact inner elastic lamina, as well as the
preservation of normal adventitial collagen. This indicates
that these acellular supportive elements are not denatured by
PDT, and contribute to the preservation of the mechanical
integrity of the vessels. Barr et al. (1987) has demonstrated
similar collagen preservation in the submucosal layers of the
rat colon treated with PDT using a sulphonated phthalo-
cyanine. Although cross-linking of collagen fibres can be
induced by singlet oxygen photo-oxidation, this process does
not appear to compromise the mechanil properties. The
absence of mural inflammation in the presence of the appar-
ent extensive cell death, together with the persistent function
of the vessels, suggests that typical cell necrosis may not be
taking place, and that the features might be consisent with a
form of programmed cell death, or apoptosis. Apoptosis has
recently been found to occur in response to photodynamic
therapy in vitro and in vivo (Agarwal et al., 1991; Okinick et
al., 1992; Zaidi et al., 1993). The exact mechanisms of cell
death in this situation remain unclear and are the subject of
further investigation.
LaMuragha et al. (1993), reporting on the distribution of
sulphonated aluminium phthalocyanine (CASPc) in both
normal carotid arteries and balloon catheter-injured arteries,
found that fluorescence was detected in the full thickness of
the arterial waLl as in the present study. Interestingly, how-
ever, they found that in normal arteries the highest fluores-
cence occurred in the adventitia in the area of small blood
vessels, with an even distribution in the media and intima -
in contrast with the findings reported here in femoral arteries,
in which both AlS2Pc and ALA-induced protoporphyrin IX
clearly demonstrated maximal levels in the intima. That PDT
in tumour therapy brings about necrosis at least in part by
virtue ofits action on the microvasculature is well established
(Bugelski et al., 1981; Henderson et al., 1985; Star et al.,
1986; Reed et al., 1988). Endothelial cells have been shown to
be highly sensitive to PDT injury, and indeed this has been
suggested to be directly responsible for the tumour necrosis
observed following PDT (Berenbaum et al., 1987, 1990; Zhou
et al., 1988; He et al., 1991). Chaudhuri et al. (1987) found
that endothelial cells were more susceptible to PDT injury
than tumour cells. Certainly the endothelium in this study
convincingly demonstrated maximal fluorescence for both
drugs used (see Figure 1), suggesting the likelihood of high
susceptibility to photodynamic injury. While relatively low
levels of fluorescence were seen in the smooth muscle of the
vascular media, treatment groups showed a dramatic re-
sponse to light exposure. Light-only and drug-only groups
showed no medial injury. Tlerefore, in spite of low fluores-
cence detection, these cells appear to be highly susceptible to
photodynamic injury. Blood vessels of this size are oxy-
genated by circulating blood in the lumen and do not have
vasa vasorum, indicating that a direct phototoxic effect was
responsible rather than the injury being secondary to
ischaemia due to microvascular shutdown.
Suzuki et al. (1987) described endotheial cell loss in aortas
of rats treated with haematoporphyrin derivative PDT. They
observed no other damage to the vessel wall and found that
endothelial cell regeneration had occurred within 5 days. The
thickness of the larger vessel studied may have allowed
preservation of the endothelium along the posterior surface
of the aorta due to limited light penetration, allowing greater
opportunity for endothelial regeneration in a shorter time. In
our study the endothelium, while showing some evidence of
regeneration at I week was not complete until 2 weeks.
Chevretton et al. (1992) reporting on skeletal muscle injury
after PDT using a variety of sensitisers noted loss of
endothelium and intravascular thrombosis in arterioles. An
eosinophilic necrosis of arteriolar smooth muscle was also
described and the changes noted to be reminiscent of those
seen in acute hypertension. These findings are similar to our
observations with the exception that there was no evidence of
thrombosis in the larger arteries examined in this study.
Arterial smooth muscle cells (SMCs) proliferate in the
intima in response to mechanical arterial wall injury. Experi-
mental balloon catheter injury in animal models has been
used to denude the endothelium and cause migration and
proliferation of SMCs resulting in the formation of neo-
intimal fibrocellular hyperplasia (Clowes et al., 1983). This
injury mimics the situation responsible for restenosis of
vessels undergoing angioplasty, endarterectomy and coronary
artery bypass grafting. A complex and incompletely under-
stood interaction between platelets, platelet-derived growth
factor (PDGF), basic fibroblast growth factor (bFGF) re-
leased by damaged cells and other cytokines and growth
factors is thought to mediate this response, which usually
becomes manifest between 7 and 21 days following injury
(Reidy, 1992; Ross, 1993). Photodynamic therapy has been
recently proposed by several authors to inhibit the develop-
ment of this intimal hyperplasia (Litvack et al., 1985; Neave
et al., 1988; Eton et al., 1992; Ortu et al., 1992). Eton et al.
(1992) using Photofrin and denuded rat carotid arteries,
found that PDT using a light dose of 7.6J cm-2 inhibited the
development of intimal hyperplasia. At 5 weeks they found
nonrmal cellular architecture in all cases with no cellular
necrosis. Ortu et al. (1992) report the effects of PDT using
5 mgkg-' chloroaluminium-sulphonated phthalocyanine and
100J cm-2 on balloon-injured rat carotid arteries. The study
demonstrated that PDT effectively inhibited the development
of intimal hyperplasia. While normal carotid arteries were
not treated with PDT in their study, Ortu et al. (1992)
observed loss of medial smooth muscle cells with a collapsed
appearance of the arterial wall and intact elastic laminae,
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similar to the findings in our study. They found arterial
diameters in treatment and control groups to be similar.
Ultrastructural examination also showed no damage to col-
lagen or elastic tissue. The arteries were examined 1 week
after PDT and 2 weeks after balloon injury, and the authors
comment that subsequent repopulation of the media in the
long term could not be excluded. These studies used experi-
mentally injured arteries in both treatment and control
groups and. while demonstrating an early inhibitory response
to the development of intimal hyperplasia. no study has
examined response at longer than 6 weeks.
The present study further looked at the long-term effects of
PDT on normal arteries at follow-up times up to 6 months in
the treated groups. Repopulation of the cell-depleted media
took from 3 to 6 months in the AlSPc groups. This repopu-
lation was associated with the observation that occasional
vessels showed intimal hyperplasia of only one or two layers'
thickness and did not appear to result in any degree of
stenosis. As no significant intimal hyperplasia was demon-
strated by 6 months in the present study group. long after
endothelial regeneration was completed. it is therefore
unlikely to develop. In the ALA group. medial repopulation
had not occurred by 6 months, and was thus similarly felt
unlikely to occur at all. This finding was difficult to explain
and suggests a local, perhaps biochemical, inhibitory effect
resulting from a difference in the nature of the injury not
detected by the morphological investigations carried out. The
effect on the treated arteries in this group was to transform
the artery into a wider bore non-contractile vessel with an
adventitia and an intima but no functional media. While
vein-grafted stenoses in man tend to undergo arterialisation
by migration of smooth muscle cells from adjacent arterial
ends (Dilley et al.. 1988). this had not taken place by 6
months. This may have clinical relevance in that vessels
treated following sensitisation with ALA may be even less
likely to develop intimal hyperplasia. A possible outcome
may be long-term weakness of the vessels and a tendency to
aneurysmal dilation. however this was not observed macro-
scopically in this study.
In spite of obvious extensive injury to both endothelial
cells and medial smooth muscle cells, neither stenosis nor
intimal proliferation of smooth muscle cells was observed in
this study. This may reflect the total nature of the injury to
the vessel walls studied leaving behind no residual SMCs in
the treated segments. A possible explanation for the lack of
intimal hyperplasia is that endothelial regeneration occurred
at a much faster rate than the medial repopulation, and once
completed acts to prevent migration of proliferating SMC.
The endothelium in balloon-denuded vessels regenerates from
the ends of the denuded segment (Clowes et al.. 1983). and it
is likely that a similar process occurs in PDT-injured vessels
for both endothelial cells and smooth muscle cells. In animal
models of intimal hyperplasia. proliferation of SMCs charac-
teristically occurs within the first few weeks following injury
and stops when the overlying endothelial layer is re-
established (Bjorkerud & Bjonders, 1973: Fishman et al..
1975; Haudenschild & Schwartz, 1979). Progressive regres-
sion and condensation of thickening is then observed in the
succeeding weeks (Fishman et al., 1975).
The cross-sectional areas determined in this study serve to
illustrate the effects of PDT injury to the vessel wall, with
significant dilation with respect to controls being observed up
to 14 days in all treatment groups. They further reflect the
observed medial repopulation in the AIS2Pc group at 6
months, confirming that functional recovery takes place in
this group and that the SMCs are phenotypically contractile.
The persistent increase in cross-sectional area in the ALA
group even at 6 months illustrates the failure to repopulate
the media with functional SMCs. A criticism of the method
is that the harvested vessels were not perfusion fixed, and
therefore may not exhibit their in vivo configuration. How-
ever. consistent results were obtained, and clearly demon-
strate a statistically significant difference in response to PDT
between controls and ALA- and AlS2Pc-treated groups.
As discussed, PDT tumour necrosis is brought about at
least in part by microvascular collapse with thrombosis and
haemorrhage; it would appear that from this study larger
vessels with sufficient supporting mural connective tissue
elements are resistant to such collapse. It remains to be
determined which size of vessel represents the cut-off point
for haemorrhage and occlusion. Furthermore, should tumour
fluorescence profiles differ significantly from those demon-
strated in large blood vessels, it may be possible to identify
times at which tumour PDT would not result in significant
vascular injury.
In conclusion, this study has demonstrated that artenres
treated with photodynamic therapy remain patent without
rupture, haemorrhage or thrombotic occlusion. Preservation
of non-cellular structural elements such as collagen and elas-
tin coupled with the lack of inflammatory response in the
arterial wall in spite of extensive cell death indicate that
mechanical integrity is preserved. Long-term patency has
been demonstrated with minimal risk of development of
intimal hyperplasia. These findings indicate that arteries
exposed to PDT during tumour therapy are unlikely to be at
risk. provided there is no direct invasion of the artery wall by
tumour, and suggest that PDT is a safe modality to use
whether as a primary treatment or as an adjunctive proce-
dure to surgery. The use of PDT to stenlise surgical fields
following clearance of primary tumour or locoregional
metastatic spread offers the potential for diminishing local
recurrence by ablating microscopic residual disease.
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